LEO Pharma continues to strengthen strategic leadership in medical dermatology with appointment of Helle Hedegaard Juhl as new EVP of Global People & Corporate Affairs

Ballerup, Denmark, June 2, 2025 – LEO Pharma, a leader in medical dermatology focused on innovative solutions for skin health, today announces the appointment of Helle Hedegaard Juhl as EVP for Global People & Corporate Affairs (GPCA). Helle will join the Global Leadership Team to lead LEO Pharma's people strategy to support its transformation and assist in developing the organization. Her appointment, alongside EVP International Operations, Frederik Kier further strengthens the company’s strategy to lead the field of medical dermatology.

Helle comes with more than 20 years of experience in a variety of HR roles within the pharmaceutical industry. After nearly 6 years as Chief Human Resources Officer at Esteve, an international specialty pharmaceutical company, headquartered in Spain, Helle will join LEO Pharma’s Global Leadership Team and head up Global People & Corporate Affairs. 

“I am really looking forward to being part of the LEO Pharma team and to meeting colleagues from across the organization as soon as possible. I’m excited to contribute to the next stage of LEO Pharma’s transformation journey as we partner to shape the future of dermatology,” says Helle.

Prior to joining the Esteve executive leadership team, Helle spent 16 years at Lundbeck, a Danish-headquartered pharmaceutical company, in various roles within the HR organization, including Global HR Manager and HR Senior Director.

“Helle has a highly experienced profile and will support our quest for becoming the global leader in medical dermatology through the people-lens, strengthening the capabilities of the HR team while focusing on shaping our unique culture, ” says CEO, Christophe Bourdon. 

The announcement of a new EVP for GPCA is part of broader leadership changes revealed in mid-May to support LEO Pharma's long-term strategy and transformation. The Product Strategy and International Operations function was split, with a new EVP for International Operations starting in June 2025 and an interim leader appointed for Global Product Strategy while the search for a permanent head is underway. At the same time, an interim EVP for Development has been appointed during the search for a permanent replacement, aiming to unlock the full potential of our strategic portfolio through global launches and expanded indications.